Skip to main content

Sars-Cov-2 (Covid-19) Mrna-Lnp Vaccine (Cvx 310) Dosage

Medically reviewed by Drugs.com. Last updated on Sep 3, 2024.

Applies to the following strengths: preservative-free 10 mcg/0.3 mL

Usual Pediatric Dose for:

Additional dosage information:

Usual Pediatric Dose for COVID-19

5 to 11 years:


Comments:

Use: Active immunization to prevent COVID-19 caused by SARS-CoV-2 in patients 5 to less than 12 years of age with at least 1 underlying condition that puts them at high-risk for severe outcomes from COVID-19

Renal Dose Adjustments

Data not available

Liver Dose Adjustments

Data not available

Precautions

CONTRAINDICATIONS:


Safety and efficacy have not been established in patients younger than 5 years.

Consult WARNINGS section for additional precautions.

Dialysis

Data not available

Other Comments

Administration advice:


Storage requirements:

Reconstitution/preparation techniques:

General:

Patient advice:

Does Sars-cov-2 (covid-19) mrna-lnp vaccine (cvx 310) interact with my other drugs?

Enter medications to view a detailed interaction report using our Drug Interaction Checker.

More about sars-cov-2 (covid-19) mrna-lnp vaccine (cvx 310)

See also:

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.